Product Code: TMRGL1849
The report provides revenue of the global smoking cessation and nicotine de-addiction market for the period 2017-2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global smoking cessation and nicotine de-addiction market from 2022 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the smoking cessation and nicotine de-addiction market.
The report delves into the competitive landscape of the global smoking cessation and nicotine de-addiction market. Key players operating in the global smoking cessation and nicotine de-addiction market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global smoking cessation and nicotine de-addiction market profiled in this report.
Table of Contents
1. Preface
- 1.1. Market Definition and Scope
- 1.2. Market Segmentation
- 1.3. Key Research Objectives
- 1.4. Research Highlights
2. Assumptions
3. Research Methodology
4. Executive Summary
5. Market Overview
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.2. Restraints
- 5.1.3. Opportunities
- 5.2. Key Trends Analysis
- 5.2.1. Demand Side Analysis
- 5.2.2. Supply Side Analysis
- 5.3. Key Market Indicators
- 5.4. Porter's Five Forces Analysis
- 5.5. Value Chain Analysis
- 5.6. Industry SWOT Analysis
- 5.7. Global Smoking Cessation and Nicotine De-Addiction Market Analysis, 2017-2031
- 5.7.1. Market Value Projections (US$ Mn)
6. Global Smoking Cessation and Nicotine De-Addiction Market Analysis and Forecast, by Product Type
- 6.1. Global Smoking Cessation and Nicotine De-Addiction Market Size (US$ Mn), by Product Type, 2017-2031
- 6.1.1. Product (with nicotine)
- 6.1.1.1. OTC Products
- 6.1.1.1.1. E-cigarettes
- 6.1.1.1.2. Nicotine Gums (NRT)
- 6.1.1.1.3. Nicotine Patches (NRT)
- 6.1.1.1.4. Nicotine Lozenges (NRT)
- 6.1.1.1.5. Nicotine Tablets (NRT)
- 6.1.1.2. Prescription Products
- 6.1.1.2.1. Nicotine Sprays (NRT)
- 6.1.1.2.2. Nicotine Inhalers (NRT)
- 6.1.2. Product (without nicotine)
- 6.1.2.1. Prescription Products
- 6.1.2.1.1. Zyban
- 6.1.2.1.2. Chantix
- 6.2. Incremental Opportunity, by Product Type
7. Global Smoking Cessation and Nicotine De-Addiction Market Analysis and Forecast, by Distribution Channel
- 7.1. Global Smoking Cessation and Nicotine De-Addiction Market Size (US$ Mn)t, By Distribution Channel, 2017-2031
- 7.1.1. Online
- 7.1.2. Offline
- 7.2. Incremental Opportunity, by Distribution Channel
8. Global Smoking Cessation and Nicotine De-Addiction Market Analysis and Forecast, Region
- 8.1. Global Smoking Cessation and Nicotine De-Addiction Market Size (US$ Mn), by Region, 2017-2031
- 8.1.1. North America
- 8.1.2. Europe
- 8.1.3. Asia Pacific
- 8.1.4. Middle East & Africa
- 8.1.5. South America
- 8.2. Incremental Opportunity, by Region
9. North America Smoking Cessation and Nicotine De-Addiction Market Analysis and Forecast
- 9.1. Regional Snapshot
- 9.2. Price Trend Analysis
- 9.2.1. Weighted Average Selling Price (US$)
- 9.3. Key Trends Analysis
- 9.3.1. Demand Side Analysis
- 9.3.2. Supply Side Analysis
- 9.4. COVID-19 Impact Analysis
- 9.5. Key Supplier Analysis
- 9.6. Consumer Buying Behavior Analysis
- 9.7. Smoking Cessation and Nicotine De-Addiction Market Size (US$ Mn), by Product Type, 2017-2031
- 9.7.1. Product (with nicotine)
- 9.7.1.1. OTC Products
- 9.7.1.1.1. E-cigarettes
- 9.7.1.1.2. Nicotine Gums (NRT)
- 9.7.1.1.3. Nicotine Patches (NRT)
- 9.7.1.1.4. Nicotine Lozenges (NRT)
- 9.7.1.1.5. Nicotine Tablets (NRT)
- 9.7.1.2. Prescription Products
- 9.7.1.2.1. Nicotine Sprays (NRT)
- 9.7.1.2.2. Nicotine Inhalers (NRT)
- 9.7.2. Product (without nicotine)
- 9.7.2.1. Prescription Products
- 9.7.2.1.1. Zyban
- 9.7.2.1.2. Chantix
- 9.8. Smoking Cessation and Nicotine De-Addiction Market Size (US$ Mn), by Distribution Channel, 2017-2031
- 9.8.1. Online
- 9.8.2. Offline
- 9.9. Smoking Cessation and Nicotine De-Addiction Market Size (US$ Mn), by Country and Sub-region, 2017-2031
- 9.9.1. U.S.
- 9.9.2. Canada
- 9.9.3. Rest of North America
- 9.10. Incremental Opportunity Analysis
10. Europe Smoking Cessation and Nicotine De-Addiction Market Analysis and Forecast
- 10.1. Regional Snapshot
- 10.2. Price Trend Analysis
- 10.2.1. Weighted Average Selling Price (US$)
- 10.3. Key Trends Analysis
- 10.3.1. Demand Side Analysis
- 10.3.2. Supply Side Analysis
- 10.4. COVID-19 Impact Analysis
- 10.5. Key Supplier Analysis
- 10.6. Consumer Buying Behavior Analysis
- 10.7. Smoking Cessation and Nicotine De-Addiction Market Size (US$ Mn), by Product Type, 2017-2031
- 10.7.1. Product (with nicotine)
- 10.7.1.1. OTC Products
- 10.7.1.1.1. E-cigarettes
- 10.7.1.1.2. Nicotine Gums (NRT)
- 10.7.1.1.3. Nicotine Patches (NRT)
- 10.7.1.1.4. Nicotine Lozenges (NRT)
- 10.7.1.1.5. Nicotine Tablets (NRT)
- 10.7.1.2. Prescription Products
- 10.7.1.2.1. Nicotine Sprays (NRT)
- 10.7.1.2.2. Nicotine Inhalers (NRT)
- 10.7.2. Product (without nicotine)
- 10.7.2.1. Prescription Products
- 10.7.2.1.1. Zyban
- 10.7.2.1.2. Chantix
- 10.8. Smoking Cessation and Nicotine De-Addiction Market Size (US$ Mn) Forecast, by Distribution Channel, 2017-2031
- 10.8.1. Online
- 10.8.2. Offline
- 10.9. Smoking Cessation and Nicotine De-Addiction Market Size (US$ Mn), by Country and Sub-region, 2017-2031
- 10.9.1. U.K.
- 10.9.2. Germany
- 10.9.3. France
- 10.9.4. Rest of Europe
- 10.10. Incremental Opportunity Analysis
11. Asia Pacific Smoking Cessation and Nicotine De-Addiction Market Analysis and Forecast
- 11.1. Regional Snapshot
- 11.2. Price Trend Analysis
- 11.2.1. Weighted Average Selling Price (US$)
- 11.3. Key Trends Analysis
- 11.3.1. Demand Side Analysis
- 11.3.2. Supply Side Analysis
- 11.4. COVID-19 Impact Analysis
- 11.5. Key Supplier Analysis
- 11.6. Consumer Buying Behavior Analysis
- 11.7. Smoking Cessation and Nicotine De-Addiction Market Size (US$ Mn), by Product Type, 2017-2031
- 11.7.1. Product (with nicotine)
- 11.7.1.1. OTC Products
- 11.7.1.1.1. E-cigarettes
- 11.7.1.1.2. Nicotine Gums (NRT)
- 11.7.1.1.3. Nicotine Patches (NRT)
- 11.7.1.1.4. Nicotine Lozenges (NRT)
- 11.7.1.1.5. Nicotine Tablets (NRT)
- 11.7.1.2. Prescription Products
- 11.7.1.2.1. Nicotine Sprays (NRT)
- 11.7.1.2.2. Nicotine Inhalers (NRT)
- 11.7.2. Product (without nicotine)
- 11.7.2.1. Prescription Products
- 11.7.2.1.1. Zyban
- 11.7.2.1.2. Chantix
- 11.8. Smoking Cessation and Nicotine De-Addiction Market Size (US$ Mn), by Distribution Channel, 2017-2031
- 11.8.1. Online
- 11.8.2. Offline
- 11.9. Smoking Cessation and Nicotine De-Addiction Market Size (US$ Mn), by Country and Sub-region, 2017-2031
- 11.9.1. China
- 11.9.2. India
- 11.9.3. Japan
- 11.9.4. Rest of Asia Pacific
- 11.10. Incremental Opportunity Analysis
12. Middle East & Africa Smoking Cessation and Nicotine De-Addiction Market Analysis and Forecast
- 12.1. Regional Snapshot
- 12.2. Price Trend Analysis
- 12.2.1. Weighted Average Selling Price (US$)
- 12.3. Key Trends Analysis
- 12.3.1. Demand Side Analysis
- 12.3.2. Supply Side Analysis
- 12.4. COVID-19 Impact Analysis
- 12.5. Key Supplier Analysis
- 12.6. Consumer Buying Behavior Analysis
- 12.7. Smoking Cessation and Nicotine De-Addiction Market Size (US$ Mn), by Product Type, 2017-2031
- 12.7.1. Product (with nicotine)
- 12.7.1.1. OTC Products
- 12.7.1.1.1. E-cigarettes
- 12.7.1.1.2. Nicotine Gums (NRT)
- 12.7.1.1.3. Nicotine Patches (NRT)
- 12.7.1.1.4. Nicotine Lozenges (NRT)
- 12.7.1.1.5. Nicotine Tablets (NRT)
- 12.7.1.2. Prescription Products
- 12.7.1.2.1. Nicotine Sprays (NRT)
- 12.7.1.2.2. Nicotine Inhalers (NRT)
- 12.7.2. Product (without nicotine)
- 12.7.2.1. Prescription Products
- 12.7.2.1.1. Zyban
- 12.7.2.1.2. Chantix
- 12.8. Smoking Cessation and Nicotine De-Addiction Market Size (US$ Mn), by Distribution Channel, 2017-2031
- 12.8.1. Online
- 12.8.2. Offline
- 12.9. Smoking Cessation and Nicotine De-Addiction Market Size (US$ Mn), by Country and Sub-region, 2017-2031
- 12.9.1. GCC
- 12.9.2. South Africa
- 12.9.3. Rest of Middle East & Africa
- 12.10. Incremental Opportunity Analysis
13. South America Smoking Cessation and Nicotine De-Addiction Market Analysis and Forecast
- 13.1. Regional Snapshot
- 13.2. Price Trend Analysis
- 13.2.1. Weighted Average Selling Price (US$)
- 13.3. Key Trends Analysis
- 13.3.1. Demand Side Analysis
- 13.3.2. Supply Side Analysis
- 13.4. COVID-19 Impact Analysis
- 13.5. Key Supplier Analysis
- 13.6. Consumer Buying Behavior Analysis
- 13.7. Smoking Cessation and Nicotine De-Addiction Market Size (US$ Mn), by Product Type, 2017-2031
- 13.7.1. Product (with nicotine)
- 13.7.1.1. OTC Products
- 13.7.1.1.1. E-cigarettes
- 13.7.1.1.2. Nicotine Gums (NRT)
- 13.7.1.1.3. Nicotine Patches (NRT)
- 13.7.1.1.4. Nicotine Lozenges (NRT)
- 13.7.1.1.5. Nicotine Tablets (NRT)
- 13.7.1.2. Prescription Products
- 13.7.1.2.1. Nicotine Sprays (NRT)
- 13.7.1.2.2. Nicotine Inhalers (NRT)
- 13.7.2. Product (without nicotine)
- 13.7.2.1. Prescription Products
- 13.7.2.1.1. Zyban
- 13.7.2.1.2. Chantix
- 13.8. Smoking Cessation and Nicotine De-Addiction Market Size (US$ Mn), by Distribution Channel, 2017-2031
- 13.8.1. Online
- 13.8.2. Offline
- 13.9. Smoking Cessation and Nicotine De-Addiction Market Size (US$ Mn), by Country and Sub-region, 2017-2031
- 13.9.1. Brazil
- 13.9.2. Rest of South America
- 13.10. Incremental Opportunity Analysis
14. Competition Landscape
- 14.1. Market Player - Competition Dashboard
- 14.2. Company Profiles (Details - Company Overview, Sales Area/Geographical Presence, Financial/Revenue, Strategy & Business Overview, Sales Channel Analysis, Size Portfolio)
- 14.2.1. Pfizer Inc.
- 14.2.1.1. Company Overview
- 14.2.1.2. Sales Area/Geographical Presence
- 14.2.1.3. Financial/Revenue
- 14.2.1.4. Strategy & Business Overview
- 14.2.1.5. Sales Channel Analysis
- 14.2.1.6. Size Portfolio
- 14.2.2. GlaxoSmithKline plc (GSK)
- 14.2.2.1. Company Overview
- 14.2.2.2. Sales Area/Geographical Presence
- 14.2.2.3. Financial/Revenue
- 14.2.2.4. Strategy & Business Overview
- 14.2.2.5. Sales Channel Analysis
- 14.2.2.6. Size Portfolio
- 14.2.3. Cipla Ltd.
- 14.2.3.1. Company Overview
- 14.2.3.2. Sales Area/Geographical Presence
- 14.2.3.3. Financial/Revenue
- 14.2.3.4. Strategy & Business Overview
- 14.2.3.5. Sales Channel Analysis
- 14.2.3.6. Size Portfolio
- 14.2.4. Johnson & Johnson (J&J)
- 14.2.4.1. Company Overview
- 14.2.4.2. Sales Area/Geographical Presence
- 14.2.4.3. Financial/Revenue
- 14.2.4.4. Strategy & Business Overview
- 14.2.4.5. Sales Channel Analysis
- 14.2.4.6. Size Portfolio
- 14.2.5. ITC Ltd.
- 14.2.5.1. Company Overview
- 14.2.5.2. Sales Area/Geographical Presence
- 14.2.5.3. Financial/Revenue
- 14.2.5.4. Strategy & Business Overview
- 14.2.5.5. Sales Channel Analysis
- 14.2.5.6. Size Portfolio
- 14.2.6. Takeda Pharmaceutical Company Ltd
- 14.2.6.1. Company Overview
- 14.2.6.2. Sales Area/Geographical Presence
- 14.2.6.3. Financial/Revenue
- 14.2.6.4. Strategy & Business Overview
- 14.2.6.5. Sales Channel Analysis
- 14.2.6.6. Size Portfolio
- 14.2.7. Alkalon A/S
- 14.2.7.1. Company Overview
- 14.2.7.2. Sales Area/Geographical Presence
- 14.2.7.3. Financial/Revenue
- 14.2.7.4. Strategy & Business Overview
- 14.2.7.5. Sales Channel Analysis
- 14.2.7.6. Size Portfolio
- 14.2.8. 22nd Century Group, Inc.
- 14.2.8.1. Company Overview
- 14.2.8.2. Sales Area/Geographical Presence
- 14.2.8.3. Financial/Revenue
- 14.2.8.4. Strategy & Business Overview
- 14.2.8.5. Sales Channel Analysis
- 14.2.8.6. Size Portfolio
- 14.2.9. Strides Pharma Science Ltd
- 14.2.9.1. Company Overview
- 14.2.9.2. Sales Area/Geographical Presence
- 14.2.9.3. Financial/Revenue
- 14.2.9.4. Strategy & Business Overview
- 14.2.9.5. Sales Channel Analysis
- 14.2.9.6. Size Portfolio
- 14.2.10. JUUL Labs, Inc.
- 14.2.10.1. Company Overview
- 14.2.10.2. Sales Area/Geographical Presence
- 14.2.10.3. Financial/Revenue
- 14.2.10.4. Strategy & Business Overview
- 14.2.10.5. Sales Channel Analysis
- 14.2.10.6. Size Portfolio
15. Key Takeaway